To further show the protective effect of TLSs in HCC patients, the numbers of CD20+ B cells, CD3+ T cells, CD8+ T cells and LAMP3+ DCs in TLSs were observed by IF/IHC (Figure 3). Here, LAMP3 is linked to hepatocellular carcinoma.